Interelationship between the duration of HIV infection, the viral load and the CD4+ lymphocyte count;Interrelación entre la duración de la infección por el virus de la inmunodeficiencia humana, la viremia plasmática y la cifra de linfocitos CD4+

Medicina Clinica

Volumn 110, Issue 14, 1998, Pages 529-531

  Soriano, Vicenç ^a,c   Gómez Cano, María ^a   Castilla, Jesús ^b   Villalba, Nieves ^a   Holgúin, África ^a   Bravo, Rosa ^a   Mas, Antonio ^a   Pérez Labad, Maria Luisa ^a   González Lahoz, Juan ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PATHOPHYSIOLOGY; STATISTICAL MODEL; SURVIVAL; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; LINEAR MODELS; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 0032565176     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wei X, Ghosh S, Taylor M, Johnson V, Emini E, Deutsch P et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (Lond) 1995; 373: 117-122.
2. Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (Lond) 1995; 373: 123-126.
3. Coffin J. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 1995; 267: 483-489.
4. Perelson A, Neumann A, Markowitz M, Leonard J, Ho D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 1.582-1.586.
5. Feinberg M. Changing the natural history of HIV disease. Lancet 1996; 348: 239-246
6. Havlir D, Richman D. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med 1996; 124: 984-994.
7. Saag M, Holodniy M, Kuritzkes D. HIV viral load markers in clinical practice. Nature Med 1996; 2: 625-629.
8. Carpenter C, Fischl M, Hammer S, Hirsch M, Jacobsen D, Katzenstein D et al. Antiretroviral therapy for HIV infection in 1996 JAMA 1996; 276: 146-154.
9. Mellors J, Kingsley L, Rinaldo C, Todd J, Hoo B, Kokka R et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122: 573-579.
10. Jurriaans S, Van Gemen B, Weverling G, Van Strijp D, Nara P, Coutinho R et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of viral course? Virology 1994; 204: 223-233.
11. Henrard D, Phillips J, Muenz L, Blattner W, Wiesner D, Eyster M et al. Natural history of HIV-1 cell-free viremia. JAMA 1995; 274: 554-558.
12. Mellors J, Rinaldo C, Gupta P, White R, Todd J, Kingsley L. Prognosis in HIV infection predicted by the quantity of virus in plasma. Science 1996; 272: 1.167-1170.
13. O'Brien T, Blattner W, Waters D, Eyster M, Hilgartner M, Cohen A et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study JAMA 1996; 276: 105-110.
14. 6/I. AIDS 1997; 11: 53-57.
15. Coffin J. HIV viral dynamics. AIDS 1996; 10 (Supl 3): 75-84.
16. Vandamme A, Schmit J, Van Dooren S, Van Laethem K, Gobbers E, Kok W et al. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor test. J AIDS Hum Retrovirol 1996; 13: 127-139.
17. Mellors J. Viral load and clinical outcome: a review of recent studies. International Workshop on HIV drug resistance. Whistler 1996 Antiviral Therapy 1996; 1 (Supl 1): 21-22.
18. Ioannidis J, Cappelleri J, Lau J, Sacks H, Skolnik P. Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS 1996; 10: 255-262.
19. Katzenstein D, Hammer S, Hughes M, Gundacker H, Jackson J, Fiscus S et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996; 335: 1.091-1.098.
20. Katzenstein T, Pedersen C, Nielsen C, Lundgren J. Jakobsen P, Gerstot J. Longitudinal serum HIV-RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996; 10: 167-173.
21. Brettle R, McNeil A, Burns S, Gore S, Bird A, Yap P et al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS 1996; 10: 419-430.
22. Dean M, Carrington M, Winkler C, Huttley G, Smith M, Allikmets R et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1.856-1.861.
23. Piatak M, Saag M, Yang L, Clark S, Kappes J, Luk K et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259: 1.749-1.754.